Published on
October 17, 2019
- 06:00 GMT
ASIT biotech Mode of Action Study of gp-ASIT+™ for Grass Pollen Allergy Published in The Journal of Allergy and Clinical ...
Data show how gp-ASIT+™, administered in a pre-seasonal 3-week treatment, is able to rapidly modulate the cellular response and induce production of blocking antibodies. This effect led to a significant reduction in the combined clinical symptom and …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
